Description
CTLA-4 (Ipilimumab Biosimilar) Human mAb was confirmed to bind to its intended target protein CTLA-4 using flow cytometry. CTLA-4 (Ipilimumab Biosimilar) Human mAb is produced at Cell Signaling Technology. Ipilimumab is an antibody directed against the extracellular region of human CTLA-4.
Target
CTLA-4
Target Alias Names
CTLA4, CTLA-4
Isotype/Mimetic
IgG1 kappa
Animal-Derived Biomaterials Used
BSA
Sequence Available
Yes
Original Discovery Method
Immunization
Antibody/Binder Origins
Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation